BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23134023)

  • 1. [Diagnosis and treatment for plasma cell leukemia].
    Miwa A
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():628-41. PubMed ID: 23134023
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
    Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
    Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandem transplants in the treatment of multiple myeloma. Pro.
    Fassas AB; Tricot G
    Clin Adv Hematol Oncol; 2004 May; 2(5):303-4. PubMed ID: 17682284
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of multiple myeloma: 2009 update.
    Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study.
    Scott EC; Heitner SB; Dibb W; Meyers G; Smith SD; Abar F; Kovacsovics T; Perez-Avraham G; Stentz A; Frires R; Dibb J; Maziarz RT
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):424-430.e1. PubMed ID: 24650974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement.
    Capalbo S; Chiefa A; Delia M; Diomede D; Liso V
    Acta Oncol; 2007; 46(2):262-4. PubMed ID: 17453381
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
    Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
    Ramadan KM; McKenna KE; Morris TC
    Lancet Oncol; 2006 Nov; 7(11):958-9. PubMed ID: 17081923
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in the treatment of patients with multiple myeloma.
    Minnema MC; van der Spek E; van de Donk NW; Lokhorst HM
    Neth J Med; 2010 Jan; 68(1):24-32. PubMed ID: 20103818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testicular invading refractory multiple myeloma during bortezomib treatment successfully treated with lenalidomide: a case report.
    Miyao K; Sakemura R; Sakai T; Tsushita N; Kato T; Niimi K; Ono Y; Sawa M
    Ann Hematol; 2014 Mar; 93(3):529-30. PubMed ID: 23820941
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma cell leukemia: concepts and management.
    Liedtke M; Medeiros BC
    Expert Rev Hematol; 2010 Oct; 3(5):543-9. PubMed ID: 21083471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of transplant-eligible symptomatic multiple myeloma].
    Nakaseko C
    Rinsho Ketsueki; 2014 Oct; 55(10):2016-26. PubMed ID: 25297767
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma cell leukemia mimicking hairy cell leukemia.
    Hanbali A; Alrajeh A; Rasheed W
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):91-2. PubMed ID: 26013472
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma cell leukemia].
    Ravinet A; Bay JO; Tournilhac O
    Bull Cancer; 2014 Nov; 101(11):1048-58. PubMed ID: 25418598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future therapeutic approach for Waldenström's macroglobulinemia.
    Souchet-Cömpain L; Choquet S; Leblond V; Nguyen S
    Immunotherapy; 2014; 6(3):333-48. PubMed ID: 24762077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib-induced cutaneous lesions in multiple myeloma patients: a case report.
    Rodríguez-Martín M; Sáez-Rodríguez M; García-Bustínduy M; Martín-Herrera A; Noda-Cabrera A
    Dermatol Online J; 2008 Nov; 14(11):14. PubMed ID: 19094852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of untreated multiple myeloma patients ineligible for autologous stem cell transplantation].
    Tsurumi H
    Rinsho Ketsueki; 2014 Oct; 55(10):2027-35. PubMed ID: 25297768
    [No Abstract]   [Full Text] [Related]  

  • 18. New treatments for multiple myeloma.
    Richardson PG; Schlossman R; Hideshima T; Anderson KC
    Oncology (Williston Park); 2005 Dec; 19(14):1781-92; discussion 1792, 1795-7. PubMed ID: 16506632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern times: back to past, back to future].
    Feliu J; Zabalza A; García-Muñoz R; Olavarría E
    Med Clin (Barc); 2012 Jul; 139(4):180-1. PubMed ID: 22281094
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma cell leukemia: three case-reports and review of literature].
    Eddou H; Mahtat el M; Zahid H; Maaroufi HE; Jennane S; Messaoudi N; Doghmi K; Mikdame M
    Ann Biol Clin (Paris); 2013; 71(6):698-702. PubMed ID: 24342791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.